摘要
目的:探讨超短波对慢性肺心病CCP患者的临床应用价值。方法:急性发作期CCP患者87例分为超短波治疗组45例和对照组42例,治疗组在常规治疗的基础上给予超短波治疗,对照组行常规治疗。治疗前后分别测定两组患者血浆中血管内皮生长因子VEGF、内皮素(ET-1)含量,动脉血氧分压(PaO2)和平均肺动脉压(mPAP)水平。结果:与对照组比较治疗组治疗后PaO2显著升高(P<0.01),VEGF、ET-1、mPAP明显降低(P<0.01)。VEGF、ET-1与PaO2呈负相关(P<0.01)、与mPAP呈正相关(P<0.01)。结论:超短波可以通过降低肺动脉高压对CCP患者起治疗作用。
Objective： To construction the clinical worth in patients with chronic cor pulmonale （CCP）. Methods： 87 cases of CCP were divided into 2 groups, a treatment group with 45 cases treated with both ultrashortwave and conventional treatment and a control group with 42 cases treated with conventional treatment.The level ofVEGF, ET-1 and PaO2, Mpap were tested before and after the treatment, respectively. Results： Compared with those of the control group, the PaO2 induced sputum was significantly increased after the treatment with ultrashortwave（P 〈 0.01）, the VEGF, ET-1 and m PAP decreased in the treatment group more significantly than those in control group（P 〈 0.01）. PaO2 was obviously negatively correlated to VEGF and ET-1, mPAP was obviously positive correlated to VEGF and ET-1. Conclusions： ultrashortwave diathermy is between for CCP patients by decreas the pulmonary hypertension.
出处
《中国医学物理学杂志》
CSCD
2007年第1期43-45,共3页
Chinese Journal of Medical Physics
关键词
超短波
肺心病
高血压
肺性
血管内皮生长因子
内皮素-1
ultrashort wave
corpulmonale obstructive
hypertension
pulmonary
vascular erdothelial growth factor
endothelin-1
